This excerpt taken from the TOSBF 6-K filed Nov 10, 2009.
6. CASH AND CASH EQUIVALENTS AND SHORT TERM INVESTMENTS
The Companys cash equivalents are invested in bankers acceptances and other short-term instruments with a rating of R-1 or higher and maturities less than 90 days at the date of purchase. The weighted average rate of return on these funds at September 30, 2009 was 1.6% [June 30, 2009 - 2.1%].
Short term investments consist of bankers acceptances and medium term note debentures totaling $23,978,292 at September 30, 2009 [June 30, 2009 - $31,161,069] with effective interest rates between 0.2% and 1.05% and maturity dates between October 2, 2009 and June 21, 2010.
Cash and cash equivalents consist of the following:
Transition Therapeutics Inc.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
September 30, 2009
(in Canadian dollars)